The Market Reports

Synopsis
The global market for Enzyme-Linked Immunosorbent Assay (ELISA) was estimated to be worth US$ 1791 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Enzyme-Linked Immunosorbent Assay (ELISA) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.
The Enzyme-Linked Immunosorbent Assay (ELISA) market is growing steadily, driven by its wide application in diagnostics, research, and quality control. ELISA is a highly sensitive and specific immunoassay used to detect and quantify proteins, hormones, antibodies, and pathogens in biological samples. It plays a critical role in clinical diagnostics for infectious diseases, autoimmune disorders, and cancer biomarkers, as well as in drug development and pharmaceutical research. Its ability to process multiple samples simultaneously, coupled with cost-effectiveness and compatibility with automation, makes ELISA a preferred choice for laboratories worldwide.
Market growth is further fueled by the increasing demand for early disease detection, advancements in immunodiagnostic technologies, and rising investment in life sciences research. The technique is also being adapted for use in point-of-care testing and high-throughput screening, improving its utility across healthcare and biotechnology sectors. However, challenges such as the risk of cross-reactivity, the need for skilled personnel, and competition from advanced molecular diagnostic tools like PCR and next-generation sequencing can limit adoption in certain areas. Despite these hurdles, ongoing innovations in assay formats and detection systems ensure that ELISA remains a cornerstone technology in both clinical and research settings.
This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (ELISA), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enzyme-Linked Immunosorbent Assay (ELISA) by region & country, by Type, and by Application.
The Enzyme-Linked Immunosorbent Assay (ELISA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (ELISA).
Market Segmentation
By Company
Thermo Fisher Scientific
Enzo Life Sciences
BioLegend
Merck
Bio-Techne
BD Biosciences
Bio-Rad Laboratorie
Aviva Systems Biology
Repligen
Lifespan Biosciences
PerkinElmer
BioVision
Innovative Research
Biomatik
Shanghai Kehua Bio-Engineering
Biomerieux
Segment by Type
Indirect ELISA
Sandwich ELISA
Competitive ELISA
Others
Segment by Application
Laboratory
Testing Institutions
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index